Navigation Links
Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
Date:5/20/2013

LAVAL, Quebec, May 20, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the 34th Annual Goldman Sachs Healthcare Conference on Tuesday, June 11, 2013 at 9:20 a.m. PT. The conference will be held at the Terranea Resort in Los Angeles, CA.

A live webcast and audio archive of the presentation will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
2. Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of Shareholders
3. Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal
4. Valeant Pharmaceuticals Provides Efinconazole Update
5. Valeant Pharmaceuticals Reports 2013 First Quarter Financial Results
6. Actavis Acquires Worldwide Rights for Valeants Metronidazole 1.3% Vaginal Gel
7. Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc.
8. American Skin Association Announces New Member Of The Board J. Michael Pearson And New Education Council Member Ryan Weldon Of Valeant Pharmaceuticals International, Inc.
9. Valeant Pharmaceuticals International, Inc. Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for its Previously Announced Acquisition of Obagi Medical Products, Inc.
10. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc.
11. Valeant Pharmaceuticals To Announce 2013 First Quarter Results On May 2, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2019)... ... June 19, 2019 , ... INDIGO Biosciences, Inc. (INDIGO), ... announced the addition of the Human MDR-1 / P-Glycoprotein Drug Interaction Assay ... and allows researchers to perform critical toxicology testing previously available only through contract ...
(Date:6/18/2019)... ... June 18, 2019 , ... Officials with American Physician ... are pleased to announce the acquisition of Leading Edge Medical Associates (LEMA), a ... physicians and 9 advanced practice clinicians care for 115,000 emergency department patients annually ...
(Date:6/16/2019)... ... June 15, 2019 , ... Lycotec Ltd, a Cambridge ... study on its new prebiotic, LycoBiotic™, which is 1,000 – 4,000 stronger than ... which were based on a proprietary composition of GA lycopene, specially developed for ...
Breaking Medicine Technology:
(Date:6/16/2019)... ... June 15, 2019 , ... All families go through tough times. When parents ... and lack of a support network, they may be unable to care for their ... the home and place them with a relative, familiar caregiver or foster family while ...
(Date:6/14/2019)... ... June 14, 2019 , ... ... Pink Bag Event® scheduled for Saturday, July 13th. UBCF is thrilled to return ... directly impacted by breast cancer. This second event was added after an overwhelming ...
(Date:6/13/2019)... ... June 13, 2019 , ... Endometriosis is a painful, inflammatory disease that occurs when ... , Painful periods , Heavy bleeding , Irregular menstruation , ... , Women’s Excellence uses the latest and newest treatment protocols in dealing with the ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... 30 Second Test (BL30SEC) has been accepted by the 2019 National Conference of ... Appendix N requirements. , The Charm BL30SEC test was validated by third ...
(Date:6/13/2019)... ... ... Hard money lenders like Monroe Funding Corporation are able to respond and approve ... If the documentation and collateral are immediately available, it’s possible to receive approval and ... with a traditional lender, which allows loans to be customized and adjusted based on ...
Breaking Medicine News(10 mins):